Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibiotic resistance: lessons for the future

R C Moellering1

  • 1Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trovafloxacin : A Viewpoint by Robert C. Moellering Jr.

Drugs·2016
Same author

Daptomycin <i>In Vitro</i> Activity against Methicillin-Resistant Staphylococcus aureus Is Enhanced by d-Cycloserine in a Mechanism Associated with a Decrease in Cell Surface Charge.

Antimicrobial agents and chemotherapy·2013
Same author

Advances in antibacterial therapy.

Transplantation proceedings·2011
Same author

Utility of peptide nucleic acid fluorescence in situ hybridization for rapid detection of Acinetobacter spp. and Pseudomonas aeruginosa.

Journal of clinical microbiology·2009
Same author

The management of infections due to drug-resistant gram-positive bacteria.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2005
Same author

In vitro activity of an oral streptogramin antimicrobial, XRP2868, against gram-positive bacteria.

Antimicrobial agents and chemotherapy·2005
Same journal

Understanding the Clone-Censor-Weight Method in Observational Studies of Antibiotic Duration.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Antimicrobial resistance is a growing threat. Novel strategies are essential, including new drug development, modifying existing agents, and targeting bacterial virulence to combat resistant bacterial strains.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • The emergence of resistant bacterial strains poses a significant and ongoing challenge in clinical settings.
  • Existing policies and antimicrobial agents have shown limited effectiveness in combating antimicrobial resistance.
  • There is a critical need for innovative approaches to address the escalating problem of bacterial resistance.

Purpose of the Study:

  • To highlight the urgent need for novel strategies to combat antimicrobial resistance.
  • To explore various promising avenues for developing new antimicrobial therapies.
  • To review current and potential future approaches in the fight against resistant bacteria.

Main Methods:

  • Review of existing literature on antimicrobial resistance.

Related Experiment Videos

  • Analysis of current and historical strategies for managing resistant bacterial infections.
  • Exploration of emerging research in novel antimicrobial development and drug potentiation.
  • Investigation into new therapeutic targets, including bacterial virulence factors and novel cellular targets.

    • Main Results:

    • Development of novel antimicrobial agents and chemical modifications of existing ones are viable strategies.
    • Antimicrobial potentiators and inhibitors of bacterial virulence or pathogenesis show promise.
    • Antisense nucleotides, while theoretically appealing, have not yet proven clinically viable.

    Conclusions:

    • Continued research into novel antimicrobial agents and resistance-breaking strategies is crucial.
    • A multi-pronged approach, including new drug discovery and targeting virulence, is necessary.
    • Overcoming antimicrobial resistance requires sustained innovation and investigation into diverse therapeutic avenues.